Mersana Therapeutics Inc (NASDAQ:MRSN) currently has a daily average trading volume of 2.79M but it saw 2184420 shares traded in last market. With a market cap of 34.86M USD, the company’s current market price of $0.28 came rising about 0.25 while comparing to the previous closing price of $0.28. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.83 and as low as $0.26. In the recent trading on the day, stock has struck highest price mark of $0.27 while lowest mark touched by it was $0.29.
JP Morgan issued its recommendations for the stock as it upgraded the price target for the stock is $5.
Over the week, MRSN’s stock price is moving -20.25% down while it is -25.19% when we observe its performance for the past one month. Year-to-date it is -86.08% down and over the past year, the stock is showing a downside performance of -80.44%.
The company is expected to be releasing its next quarterly report on 2025-May-15, for which analysts forecasted an EPS of -0.17 while estimate for next year EPS is -0.6. In next quarter, company is expected to be making quarterly sales of $6.15M as analysts are expecting the sales for current fiscal year at $22.16M and seeing the company making $42.56M in sales next year. Moreover, analysts are in estimates of $6.06M for current-quarter revenue.
Currently, Mersana Therapeutics Inc’s total number of outstanding shares is 124.63M with 1.48% of that held by the insiders while 71.49% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -505.14%. Stock’s beta reads 0.83. Stock has a price to sale or P/S ratio amounts to 1.02. Its return on asset (ROA) is -47.62% on average.
#
